Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Arthritis Care Res (Hoboken) ; 75(7): 1588-1594, 2023 07.
Artigo em Inglês | MEDLINE | ID: mdl-35876631

RESUMO

OBJECTIVE: Many patients with fibromyalgia (FM) report using cannabis as a strategy to improve pain. Given that pain often co-occurs with symptoms of anxiety and depression (i.e., negative affect) and sleep problems among patients with FM, improvements in these symptoms might indirectly contribute to reductions in pain intensity following cannabis use. The main objective of the study was to examine whether changes in pain intensity following initiation of medical cannabis among patients with FM could be attributed to concurrent changes (i.e., reductions) in negative affect and sleep problems. METHODS: This was a 12-month prospective cohort study among patients with FM (n = 323) initiating medical cannabis under the care of physicians. Patients were assessed at baseline, and follow-up assessment visits occurred every 3 months after initiation of medical cannabis. Patients' levels of pain intensity, negative affect, and sleep problems were assessed across all visits. RESULTS: Multilevel mediation analyses indicated that reductions in patients' levels of pain intensity were partly explained by concurrent reductions in sleep problems and negative affect (both P < 0.001). This remained significant even when accounting for patients' baseline characteristics or changes in medical cannabis directives over time (all P > 0.05). CONCLUSION: Our findings provide preliminary insight into the potential mechanisms of action underlying pain reductions among patients with FM who are using medical cannabis. Given the high attrition rate (i.e., 75%) observed in the present study at 12 months, our findings cannot be generalized to all patients with FM who are using medical cannabis.


Assuntos
Fibromialgia , Maconha Medicinal , Transtornos do Sono-Vigília , Humanos , Fibromialgia/diagnóstico , Fibromialgia/tratamento farmacológico , Fibromialgia/epidemiologia , Maconha Medicinal/efeitos adversos , Estudos Prospectivos , Dor , Transtornos do Sono-Vigília/diagnóstico , Transtornos do Sono-Vigília/tratamento farmacológico , Transtornos do Sono-Vigília/epidemiologia
2.
J Biomech Eng ; 142(2)2020 02 01.
Artigo em Inglês | MEDLINE | ID: mdl-31074768

RESUMO

Wall shear stress (WSS) has been shown to be associated with myocardial infarction (MI) and progression of atherosclerosis. Wall elasticity is an important feature of hemodynamic modeling affecting WSS calculations. The objective of this study was to investigate the role of wall elasticity on WSS, and justify use of either rigid or elastic models in future studies. Digital anatomic models of the aorta and coronaries were created based on coronary computed tomography angiography (CCTA) in four patients. Hemodynamics was computed in rigid and elastic models using a finite element flow solver. WSS in five timepoints in the cardiac cycle and time averaged wall shear stress (TAWSS) were compared between the models at each 3 mm subsegment and 4 arcs in cross sections along the centerlines of coronaries. In the left main (LM), proximal left anterior descending (LAD), left circumflex (LCX), and proximal right coronary artery (RCA) of the elastic model, the mean percent radial increase 5.95 ± 1.25, 4.02 ± 0.97, 4.08 ± 0.94, and 4.84 ± 1.05%, respectively. WSS at each timepoint in the cardiac cycle had slightly different values; however, when averaged over the cardiac cycle, there were negligible differences between the models. In both the subsegments (n = 704) and subarc analysis, TAWSS in the two models were highly correlated (r = 0.99). In investigation on the effect of coronary wall elasticity on WSS in CCTA-based models, the results of this study show no significant differences in TAWSS justifying using rigid wall models for future larger studies.


Assuntos
Vasos Coronários , Hemodinâmica , Doença da Artéria Coronariana , Elasticidade , Humanos , Modelos Cardiovasculares , Resistência ao Cisalhamento , Estresse Mecânico
3.
Front Neurol ; 10: 1383, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-32010045

RESUMO

Purpose: Hemifacial spasm (HFS), a rare neuromuscular movement disorder, is characterized by unilateral, irregular, and paroxysmal facial muscle contractions. To explore the central neural mechanisms of HFS, we conducted vertex-wise shape analyses to investigate volume and shape alterations of subcortical structures, which could help to better understand the abnormality in distinct subcortical regions and determine alternative biomarkers of HFS. Methods: Thirty patients with HFS and 30 age- and sex-matched healthy controls provided written informed consent. T1-weighted structural magnetic resonance imaging (MRI) data were collected from all participants. Vertex-wise shape analyses were performed to assess the volume and shape alterations of subcortical structures following HFS. Post hoc correlations with spasm severity and measures of mood dysfunction were applied to characterize subcortical brain alterations. Results: Compared with healthy controls, patients with HFS showed increased volume in the right caudate specifically. Furthermore, patients exhibited significant shape atrophy in the anterior medial aspect of left pallidum, together with shape expansion in the anterior ventrolateral aspect of right caudate head. In addition, shape alteration in right caudate was positively correlated with both anxiety and depression severity in patients with HFS. Conclusions: This is the first study to employ vertex-wise shape analysis to investigate subcortical brain abnormalities in patients with HFS. Our findings provide compelling evidence for subcortical brain alterations specific to HFS, and further may shed light on the pathophysiology of HFS and apply to the translational medicine.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...